Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2013 Jul 10;23(11):10.1016/j.euroneuro.2013.05.014. doi: 10.1016/j.euroneuro.2013.05.014

Figure 2. Interaction of the ADRA1 and DBH genotypes with percentage of cocaine positive urines.

Figure 2

Urine toxicology screens are shown for each 2-week time period across the 12-week trial for the placebo (solid line) versus disulfiram (250mg/day) (dashed line) treatment groups. Patients with the responsive ADRA1A TT/TC and DBH CC genotype combination (N=23; disulfiram = 10, placebo = 13) are shown in the top graph. Patients with the ADRA1A CC genotype and those with DBH CT/TT genotype (N=46; disulfiram = 22; placebo = 24) are shown in the bottom graph. Standard error bars are shown at each time point.